Protein Thermodynamic Destabilization in the Assessment of Pathogenicity of a Variant of Uncertain Significance in Cardiac Myosin Binding Protein C.
Calorimetry, Differential Scanning
Cardiomyopathy, Hypertrophic, Familial
/ diagnostic imaging
Carrier Proteins
/ chemistry
Circular Dichroism
Databases, Genetic
Genetic Predisposition to Disease
High-Throughput Nucleotide Sequencing
Humans
Mutation, Missense
Phenotype
Protein Conformation
Protein Stability
Structure-Activity Relationship
Workflow
HCM
VUS
cMyBC
Journal
Journal of cardiovascular translational research
ISSN: 1937-5395
Titre abrégé: J Cardiovasc Transl Res
Pays: United States
ID NLM: 101468585
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
18
10
2019
accepted:
20
01
2020
pubmed:
9
2
2020
medline:
15
12
2020
entrez:
9
2
2020
Statut:
ppublish
Résumé
In the era of next generation sequencing (NGS), genetic testing for inherited disorders identifies an ever-increasing number of variants whose pathogenicity remains unclear. These variants of uncertain significance (VUS) limit the reach of genetic testing in clinical practice. The VUS for hypertrophic cardiomyopathy (HCM), the most common familial heart disease, constitute over 60% of entries for missense variants shown in ClinVar database. We have studied a novel VUS (c.1809T>G-p.I603M) in the most frequently mutated gene in HCM, MYBPC3, which codes for cardiac myosin-binding protein C (cMyBPC). Our determinations of pathogenicity integrate bioinformatics evaluation and functional studies of RNA splicing and protein thermodynamic stability. In silico prediction and mRNA analysis indicated no alteration of RNA splicing induced by the variant. At the protein level, the p.I603M mutation maps to the C4 domain of cMyBPC. Although the mutation does not perturb much the overall structure of the C4 domain, the stability of C4 I603M is severely compromised as detected by circular dichroism and differential scanning calorimetry experiments. Taking into account the highly destabilizing effect of the mutation in the structure of C4, we propose reclassification of variant p.I603M as likely pathogenic. Looking into the future, the workflow described here can be used to refine the assignment of pathogenicity of variants of uncertain significance in MYBPC3.
Identifiants
pubmed: 32034629
doi: 10.1007/s12265-020-09959-6
pii: 10.1007/s12265-020-09959-6
doi:
Substances chimiques
Carrier Proteins
0
myosin-binding protein C
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM